Veronica Silva

CATALIS welcomes new partners

Veronica Silva
June 13, 2018

The CATALIS Quebec Clinical Trials initiative has announced new public partners and industry funding as it moves closer to its goal of doubling private sector investment in the province’s early stage clinical trials (ESCT) and providing patients early access to innovative healthcare.

... Please become a Member or login to read the rest of this article ...


Other stories mentioning these organizations, people and topics
Organizations: AbbVie Canada, Centre hospitalier universitaire (CHU) de Québec-Université Laval, Centre hospitalier universitaire de Sherbrooke, Encycle Therapeutics, enGene, GlaxoSmithKline, IMAGINE SPOR, le Centre hospitalier universitaire de Montréal, le Centre universitaire de santé McGill, Merck Canada, Montreal InVivo, Montreal Neurological Institute, NuBiyota, Pfizer Canada, Servier Canada, and Takeda Canada
People: Danika Laberge, Dr Serge Rivest, and Gamze Yuceland
Topics: CATALIS, early stage clinical trials, Quebec Life Science Strategy 2017-2027, and Quebec provincial Budget

Other News

Economic Strategy Tables to inject industry priorities into government policy making and future funding

CMC works with Singapore’s AMF for photonics design help for Canadian researchers

Mitacs Entrepreneur Awardees

Reports: Q1 2018 records strong VC interest, but PE growth ‘slow’






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 0 free articles remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.